Altimmune Inc
NASDAQ:ALT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Altimmune Inc
NASDAQ:ALT
|
US |
|
S
|
Samyang Foods Co Ltd
KRX:003230
|
KR |
|
Euronet Worldwide Inc
NASDAQ:EEFT
|
US |
|
F
|
Fastenal Co
F:FAS
|
US |
|
Cimpress PLC
NASDAQ:CMPR
|
IE |
|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
AU |
|
Y
|
YGGDRAZIL Group PCL
SET:YGG
|
TH |
|
MainStreet Bancshares Inc
NASDAQ:MNSB
|
US |
|
Caisse regionale de Credit Agricole Mutuel d'Ille-et-Vilaine
PAR:CIV
|
FR |
|
Brickability Group PLC
LSE:BRCK
|
UK |
Wall Street
Price Targets
ALT Price Targets Summary
Altimmune Inc
According to Wall Street analysts, the average 1-year price target for
ALT
is 19.58 USD
with a low forecast of 1.01 USD and a high forecast of 29.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALT's stock price target?
Price Target
19.58
USD
According to Wall Street analysts, the average 1-year price target for
ALT
is 19.58 USD
with a low forecast of 1.01 USD and a high forecast of 29.4 USD.
What is Altimmune Inc's Revenue forecast?
Projected CAGR
1 323%
For the last 14 years the
compound annual growth rate for
Altimmune Inc's revenue is
-37%.
The projected
CAGR
for the next 3 years is
1 323%.
